EventsOHOW 2026 – The 5th International Symposium on One Health, One World
Published
This submission belongs to event OHOW 2026 – The 5th International Symposium on One Health, One World
Published date
18 Nov, 2026
Citation
Norito Ozeki, Makoto Kondo, Yukiko Matsunaga, A microphysiological human blood vessel model reveals drug-induced changes in the release of cancer cells into the circulation, in Proceedings of OHOW 2026 – The 5th International Symposium on One Health, One World, Hanoi, 26 November–28 November 2026, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

A microphysiological human blood vessel model reveals drug-induced changes in the release of cancer cells into the circulation

Makoto Kondo 1,2
Yukiko Matsunaga 1,2
1. Department of Mechanical and Biofunctional Systems, Institute of Industrial Science, The University of Tokyo, Tokyo, 153-8505, Japan
2. Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, Tokyo, 113-8656, Japan
Abstract

According to GLOBOCAN 2024 estimates, Asia accounted for 56.5% of the world's 9.8 million cancer deaths but only 50.7% of new cases, largely due to lower survival rates. The majority of cancer deaths are caused by metastasis, a process that begins when tumor cells invade blood vessels —a step known as intravasation. Tracking this initial step in living body using the animal model is difficult because it happens unpredictably, involves few cells, and occurs deep within opaque tissue.

 

To overcome this limitation, we developed a microphysiological human blood vessel model[YM1] . In this platform, tumor organoids are cultured beside a single engineered human blood vessel lined with endothelial cells, allowing us to continuously monitor how cells enter the vessel using confocal microscopy. Entering a vessel is a mechanical event: cells deform, cross the endothelial wall either as cohesive clusters or as dissociated single cells. We therefore targeted Rho-associated protein kinase (ROCK), a molecule that drives the contraction of cells, and compared how tumor cells entered the vessel when its activity was blocked.

 

Under control conditions, tumor cells entered the vessel lumen as cohesive multicellular clusters; however, when ROCK was inhibited, they appeared within the vessel lumen as individual cells or small groups. While ROCK is well known to regulate cell migration, this observation suggests the possibility that the same machinery also governs the manner in which tumor cells are released into a vessel. Although whether the released cells retain the capacity to form metastases remains to be examined, the result shows that the manner of release is open to pharmacological control, and that the vessel model resolves a difference that cannot be recovered from counts of circulating tumor cells.

Keywords
cancer metastasis; intravasation; circulating tumor cells; microphysiological system; ROCK inhibitor
A Conceptual Model of Satellite-Intelligence Platform for Risk Management System On Oil Palm Plantation and Tropical Peatland Environments
Development of Screen-Printed Disposable 3-in-1 Electrodes for On-Site Heavy Metals Analyzers